Effect of vinpocetine on retrograde axoplasmic transport

Annals of Anatomy

Volumn 189, Issue 1, 2007, Pages 39-45

  Knyihar Csillik, Elizabeth ^a   Vecsei, Laszlo ^a   Mihaly, Andras ^a   Fenyo, Robert ^a   Farkas, Ibolya ^a   Krisztin Peva, Beata ^a   Csillik, Bertalan ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Axoplasmic transport; Nerve growth factor; Pain; Vinca alkaloids

Indexed keywords

ACID PHOSPHATASE; ACID PHOSPHATASE FLUORIDE RESISTANT ISOENZYME; CALCITONIN GENE RELATED PEPTIDE; NERVE GROWTH FACTOR; PHOSPHATASE; SUBSTANCE P; THIAMINE MONOPHOSPHATASE; UNCLASSIFIED DRUG; VINPOCETINE;

ANIMAL TISSUE; ARTICLE; CEREBROVASCULAR DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; INTRACTABLE PAIN; MALE; NERVE DEGENERATION; NOCICEPTION; NONHUMAN; PERIPHERAL NERVE; PILOT STUDY; RAT; RETROGRADE NERVE FIBER TRANSPORT; SCIATIC NERVE; SPINAL CORD DORSAL HORN; TRANSGANGLIONIC DEGENERATIVE ATROPHY;

VINCA;

EID: 33846026353     PISSN: 09409602     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aanat.2006.07.006     Document Type: Article

References (35)

1. Bonoczk P., Gulyas B., Adam-Vizi V., Nemes A., Karpati E., Kiss B., Kapas M., Szantay C., Koncz I., Zelles T., and Vas A. Role of sodium channel inhibition in neuroprotection: effect of vinpocetine. Brain Res. Bull. 53 (2000) 245-254
2. Csillik B., and Knyihar-Csillik E. The Protean Gate. Structure and Plasticity of the Primary Nociceptive Analyzer (1986), Akademiai Kiado, Budapest pp. 1-294
3. Csillik B., Knyihar E., and Elshiek A.A. Degenerative atrophy of central terminals of primary sensory neurons induced by blockade of axoplasmic transport in peripheral nerves. Experientia 33 (1977) 656-657
4. Csillik B., Knyihar-Csillik E., and Szucs A. Treatment of chronic pain with iontophoresis of vinca alkaloids to the skin of patients. Neurosci. Lett. 31 (1982) 87-90
5. Csillik B., Schwab ME., and Thoenen H. Transganglionic regulation of central terminals of dorsal root ganglion cells by nerve growth factor. Brain Res. 331 (1985) 11-15
6. Csillik B., Knyihar-Csillik E., and Bezzegh A. Comparative electron histochemistry of thiamine monophosphatase and substance P in the upper dorsal horn. Acta Histochem. 80 (1986) 125-134
7. Csillik B., Janka Z., Boncz I., Kalman J., Mihaly A., Vecsei L., and Knyihar E. Molecular plasticity of primary nociceptive neurons: relations of the NGF-c-jun system to neurotomy and chronic pain. Ann. Anat. 185 (2003) 303-314
8. Erdo S.L., Cai N.S., Wolff J.R., and Kiss B. Vinpocetin protects against excitotoxic cell death in primary cultures of rat cerebral cortex. Eur. J. Pharmacol. 187 (1990) 551-553
9. Glykys J., Guadama M., Marcano L., Ochoa E., and Eblen-Zajjur A. Inflammation induced increase of fluoride resistant acid phosphatase (FRAP) activity in the spinal dorsal horn of rats. Neurosci. Lett. 337 (2003) 167-169
10. Hua L., Weisan P., Jiayu L., and Ying Z. Preparation, evaluation, and NMR characterization of vinpocetine microemulsion for transdermal delivery. Drug Dev. Ind. Pharm 30 (2004) 657-666
11. Kiss B., Cai NS., and Erdo S.L. Vinpocetine preferentially antagonizes quisqualate/AMPA receptor responses: evidence from release and ligand binding studies. Eur. J. Pharmacol. 209 (1991) 109-112
12. Knyihar E. Fluoride resistant acid phosphatase system of nociceptive dorsal root afferents. Experientia 27 (1971) 1205-1207
13. Knyihar E., and Csillik B. Axonal labyrinths in the rat spinal cord: a consequence of degenerative atrophy. Acta Biol. Acad. Sci. Hung. 27 (1976) 299-308
14. Knyihar E., and Csillik B. Plasticity of nociception: recent advances in function-oriented structural pain research. Clin. Neurosci./Ideggy Szle 59 (2006) 87-97
15. Knyihar-Csillik E., and Csillik B. FRAP: histochemistry of the primary nociceptive neuron. Prog. Histochem. Cytochem. 14 (1981) 1-137
16. Knyihar-Csillik E., Szucs A., and Csillik B. Iontophoretically applied microtubule inhibitors induce transganglionic degenerative atrophy of primary central nociceptiv terminals and abolish chronic autochtonous pain. Acta Neurol. Scand. 66 (1982) 401-412
17. Knyihar-Csillik E., Bezzegh A., Boti S., and Csillik B. Thiamine monophosphatase: a genuine marker for transganglionic regulation of primary sensory neurons. J. Histochem. Cytochem. 34 (1986) 363-371
18. Krieglstein J., and Rischke R. Vinpocetine increases the neuroprotective effect of adenosine in vitro. Eur. J. Pharmacol. 205 (1991) 7-10
19. Lendvai B., Zelles T., Rozsa B., and Vizi E.S. A vinca alkaloid enhances morphological dynamics of dendritic spines of neocortical layer 2/3 pyramidal cells. Brain Res. Bull. 59 (2003) 257-260
20. Lorincz C., Szasz K., and Kisfaludy L. The synthesis of ethyl apovincaminate. Arzneimittelforschung 26 (1976) 1907
21. Musaev A.V., Balakishieva F.K., and Nabiev N.N. The therapeutic action of cavinton electrophoresis in cerebrovascular diseases. Vopr Kurort Fizioter Lech Fiz Kult 3 (1998) 19-22
22. O'Brien C., Woolf C.J., Fitzgerald M., Lindsay R.M., and Molander C. Differences in the chemical expression of rat primary afferent neurons which innervate skin, muscle or joint. Neuroscience 32 (1989) 493-502
23. Rischke R., and Krieglstein J. Effects of vinpocetine on local cerebral flow and glucose utilization seven days after forebrain ischemia in the rat. Pharmacology 41 (1990) 153-160
24. Rohrer H., and Barde Y.-A. Presence and disappearance of NGF receptors on sensory neurons in culture. Dev. Biol. 89 (1981) 309-315
25. Rossano C., De Lucat L.F., Firetto V., Fossi F., Vannini S., Memeo R., Giugliano F., and Fogliardi A. Vinca alkaloids administered by iontophoresis in postherapeutic pain: a preliminary report. Pain Clin. 3 (1989) 31-36
26. Sauer D., Rischke R., Beck T., Rossberg C., Mennel H.D., Bielenberg G.W., and Krieglstein J. Vinpocetine prevents ischemic cell damage in rat hippocampus. Life Sci. 43 (1988) 1733-1739
27. Schoenen J., Van Hees J., Gybels J., de Castro Costa M., and Vanderhaeghen J.J. Histochemical changes of substance P, FRAP, serotonin and succinic dehydrogenase in the spinal cord of rats with adjuvant arthritis. Life Sci. 36 (1985) 1247-1254
28. Sitges M., and Nekrassov V. Vinpocetine selectively inhibits neurotransmitter release triggered by sodium channel activation. Neurochem. Res. 24 (1999) 1585-1591
29. Sitges M., Galvan E., and Nekrassov V. Vinpocetine blockade of sodium channels inhibits the rise in sodium and calcium induced by 4-aminopyridine in synaptosomes. Neurochem. Int. 46 (2005) 533-540
30. Snyder W.D., and McMahon S.B. Tackling pain at the source: new ideas about nociceptors. Neuron 20 (1998) 629-632
31. Szucs A., Csillik B., and Knyihar-Csillik E. Treatment of terminal pain in cancer patients by means of iontophoresis of vinca alkaloids. Recent Results Cancer Res. 89 (1984) 185-189
32. Tajti J., Somogyi I., and Szilard J. Treatment of chronic pain syndromes with transcutaneous iontophoresis of vinca alkaloids, with special regards to post-herpetic neuralgia. Acta Med. Hung. 46 (1989) 3-12
33. Wall P.D. Pain in the brain and lower parts of the anatomy. Pain 62 (1995) 389-393
34. Zamboni L., and De Martino C. Buffered picric acid-formaldehyde: a new rapid fixative for electron microscopy. J. Cell Biol. 35 (1965) 148A
35. Zhou X., Dong X.W., Crona J., Maguire M., and Priestley T. Vinpocetine is a potent blocker of rat NaV18 tetrodotoxin-resistant sodium channels. J. Pharmacol. Exp. Ther. 306 (2003) 498-504